19 December 2024NewsAmericasRachel Elsby Partner Akin, Renee Fuller Senior Corporate Counsel Innovation Law Bristol Myers Squibb, Alexis Simpson Senior Counsel II Patent Strategy & Analytics Gilead Sciences, Nathaniel Leachman Senior Corporate Counsel Pfizer
WATCH: AI and machine learning in drug discovery - patenting AI-generated inventions
Speakers from Akin, Bristol Myers Squibb, Gilead Sciences, and Pfizer discuss how AI accelerates drug discovery, from target identification to predictive modelling, reducing costs and enhancing therapeutic outcomes.
